Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu metaanalýza, systematický přehled, časopisecké články
Grantová podpora
Aarhus University
R140-A9482-B2407
Danish Heart Foundation
R64-A3194-B1667
Health Research Foundation of Central Denmark Region
Gangstedfonden
PhD2021011-HF
Danish Cardiovascular Academy
PubMed
37695316
PubMed Central
PMC10507669
DOI
10.1093/europace/euad267
PII: 7268805
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiac resynchronization therapy, Clinical outcomes, Echocardiographic outcomes, Electrically, Guided, Imaging, Latest activation, Targeting left ventricular lead position,
- MeSH
- echokardiografie MeSH
- hospitalizace MeSH
- lidé MeSH
- srdeční komory diagnostické zobrazování MeSH
- srdeční resynchronizační terapie * škodlivé účinky MeSH
- srdeční selhání * diagnóza terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- systematický přehled MeSH
AIMS: Several studies have evaluated the use of electrically- or imaging-guided left ventricular (LV) lead placement in cardiac resynchronization therapy (CRT) recipients. We aimed to assess evidence for a guided strategy that targets LV lead position to the site of latest LV activation. METHODS AND RESULTS: A systematic review and meta-analysis was performed for randomized controlled trials (RCTs) until March 2023 that evaluated electrically- or imaging-guided LV lead positioning on clinical and echocardiographic outcomes. The primary endpoint was a composite of all-cause mortality and heart failure hospitalization, and secondary endpoints were quality of life, 6-min walk test (6MWT), QRS duration, LV end-systolic volume, and LV ejection fraction. We included eight RCTs that comprised 1323 patients. Six RCTs compared guided strategy (n = 638) to routine (n = 468), and two RCTs compared different guiding strategies head-to-head: electrically- (n = 111) vs. imaging-guided (n = 106). Compared to routine, a guided strategy did not significantly reduce the risk of the primary endpoint after 12-24 (RR 0.83, 95% CI 0.52-1.33) months. A guided strategy was associated with slight improvement in 6MWT distance after 6 months of follow-up of absolute 18 (95% CI 6-30) m between groups, but not in remaining secondary endpoints. None of the secondary endpoints differed between the guided strategies. CONCLUSION: In this study, a CRT implantation strategy that targets the latest LV activation did not improve survival or reduce heart failure hospitalizations.
Arrhythmia Section Skaane University Hospital Lund Sweden
Department of Cardiac Surgery Na Homolce Hospital Prague Czech Republic
Department of Cardiology Aalborg University Hospital Aalborg Denmark
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic
Department of Cardiology Kristianstad Hospital Kristianstad Sweden
Diagnostic Center Silkeborg Regional Hospital Falkevej 1A 8600 Silkeborg Denmark
Faculty of Medicine Charles University Hradec Králové Czech Republic
Faculty of Medicine Hebrew University Jerusalem Israel
Jesselson Integrated Heart Center Shaare Zedek Medical Center Jerusalem Israel
Leviev Heart Institute The Chaim Sheba Medical Center Tel Hashomer Israel
Sackler School of Medicine Tel Aviv University Tel Aviv Israel
Zobrazit více v PubMed
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IMet al. . 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Europace 2022;24:71–164. PubMed
Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger Let al. . The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 2005;352:1539–49. PubMed
Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado Vet al. . Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. Europace 2021;23:1324–42. PubMed
Kronborg MB, Mortensen PT, Kirkfeldt RE, Nielsen JC. Very long term follow-up of cardiac resynchronization therapy: clinical outcome and predictors of mortality. Eur J Heart Fail 2008;10:796–801. PubMed
Mullens W, Grimm RA, Verga T, Dresing T, Starling RC, Wilkoff BLet al. . Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 2009;53:765–73. PubMed
Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni Get al. . Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol 2009;20:764–8. PubMed
Thébault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MRet al. . Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J 2012;33:2662–71. PubMed
Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada Aet al. . Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159–66. PubMed
Delgado V, van Bommel RJ, Bertini M, Borleffs CJW, Marsan NA, Arnold CTet al. . Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 2011;123:70–8. PubMed
Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik Met al. . Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012;59:1509–18. PubMed
Saba S, Marek J, Schwartzman D, Jain S, Adelstein E, White Pet al. . Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail 2013;6:427–34. PubMed
Sommer A, Kronborg MB, Nørgaard BL, Poulsen SH, Bouchelouche K, Bottcher Met al. . Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial. Eur J Heart Fail 2016;18:1365–74. PubMed
Borgquist R, Carlsson M, Markstad H, Werther-Evaldsson A, Ostenfeld E, Roijer Aet al. . Cardiac resynchronization therapy guided by echocardiography, MRI, and CT imaging: a randomized controlled study. JACC Clin Electrophysiol 2020;6:1300–9. PubMed
Glikson M, Beinart R, Golovchiner G, Sheshet AB, Swissa M, Bolous Met al. . Radial strain imaging-guided lead placement for improving response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy: the Raise CRT trial. Europace 2022;24:835–44. PubMed
Singh JP, Berger RD, Doshi RN, Lloyd M, Moore D, Stone Jet al. . Targeted left ventricular lead implantation strategy for non-left bundle branch block patients: the ENHANCE CRT study. JACC Clin Electrophysiol 2020;6:1171–81. PubMed
Kočková R, Sedláček K, Wichterle D, Šikula V, Tintěra J, Jansová Het al. . Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: a prospective, single-centre randomized study (CMR-CRT). Int J Cardiol 2018;270:325–30. PubMed
Stephansen C, Sommer A, Kronborg MB, Jensen JM, Nørgaard BL, Gerdes Cet al. . Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial. Europace 2019;21:1369–77. PubMed
Hu X, Xu H, Hassea SRA, Qian Z, Wang Y, Zhang Xet al. . Comparative efficacy of image-guided techniques in cardiac resynchronization therapy: a meta-analysis. BMC Cardiovasc Disord 2021;21:255. PubMed PMC
Jin Y, Zhang Q, Mao JL, He B. Image-guided left ventricular lead placement in cardiac resynchronization therapy for patients with heart failure: a meta-analysis. BMC Cardiovasc Disord 2015;15:36. PubMed PMC
Kheiri B, Przybylowicz R, Simpson TF, Merrill M, Osman M, Dalouk Ket al. . Imaging-guided cardiac resynchronization therapy: a meta-analysis of randomized controlled trials. Pacing Clin Electrophysiol 2021;44:1570–6. PubMed
Allen LaPointe NM, Ali-Ahmed F, Dalgaard F, Kosinski AS, Schmidler GS, Al-Khatib SM. Outcomes of cardiac resynchronization therapy with image-guided left ventricular lead placement at the site of latest mechanical activation: a systematic review and meta-analysis. J Interv Cardiol 2022;2022:6285894. PubMed PMC
Mehta VS, Ayis S, Elliott MK, Widjesuriya N, Kardaman N, Gould Jet al. . The role of guidance in delivering cardiac resynchronization therapy: a systematic review and network meta-analysis. Heart Rhythm O2 2022;3:482–92. PubMed PMC
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJet al. . Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12. PubMed
Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. www.training.cochrane.org/handbook.
Borgquist R, Barrington WR, Bakos Z, Werther-Evaldsson A, Saba S. Targeting the latest site of left ventricular mechanical activation is associated with improved long-term outcomes for recipients of cardiac resynchronization therapy. Heart Rhythm O2 2022;3:377–84. PubMed PMC
Fyenbo DB, Sommer A, Nørgaard BL, Kronborg MB, Kristensen J, Gerdes Cet al. . Long-term outcomes in a randomized controlled trial of multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy. Europace 2022;24:828–34. PubMed
Kydd AC, Khan FZ, Watson WD, Pugh PJ, Virdee MS, Dutka DP. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET study cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy). JACC Heart Fail 2014;2:205–12. PubMed
Marek JJ, Saba S, Onishi T, Ryo K, Schwartzman D, Adelstein ECet al. . Usefulness of echocardiographically guided left ventricular lead placement for cardiac resynchronization therapy in patients with intermediate QRS width and non-left bundle branch block morphology. Am J Cardiol 2014;113:107–16. PubMed
Adelstein E, Alam MB, Schwartzman D, Jain S, Marek J, Gorcsan Jet al. . Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial). Am J Cardiol 2014;113:1518–22. PubMed
Chalil S, Stegemann B, Muhyaldeen SA, Khadjooi K, Foley PW, Smith REet al. . Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;30:1201–9. PubMed
Maffessanti F, Jadczyk T, Wilczek J, Conte G, Caputo ML, Gołba KSet al. . Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy. Europace 2023;25:546–53. PubMed PMC
Costa CM, Neic A, Kerfoot E, Porter B, Sieniewicz B, Gould Jet al. . Pacing in proximity to scar during cardiac resynchronization therapy increases local dispersion of repolarization and susceptibility to ventricular arrhythmogenesis. HeartRrhythm 2019;16:1475–83. PubMed PMC
Gold MR, Birgersdotter-Green U, Singh JP, Ellenbogen KA, Yu Y, Meyer TEet al. . The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J 2011;32:2516–24. PubMed PMC
Parreira L, Tsyganov A, Artyukhina E, Vernooy K, Tondo C, Adragao Pet al. . Non-invasive three-dimensional electrical activation mapping to predict cardiac resynchronization therapy response: site of latest left ventricular activation relative to pacing site. Europace 2023;25:1458–66. PubMed PMC
Sommer A, Kronborg MB, Nørgaard BL, Stephansen C, Poulsen SH, Kristensen Jet al. . Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position. Europace 2018;20:1630–7. PubMed
Rickard J, Jackson K, Gold M, Biffi M, Ziacchi M, Silverstein Jet al. . Electrocardiogram belt guidance for left ventricular lead placement and biventricular pacing optimization. Heart rhythm 2023;20:537–44. PubMed
Sedova KA, van Dam PM, Sbrollini A, Burattini L, Necasova L, Blahova Met al. . Assessment of electrical dyssynchrony in cardiac resynchronization therapy: 12-lead electrocardiogram vs 96-lead body surface map. Europace 2023;25:554–60. PubMed PMC
Waddingham PH, Mangual JO, Orini M, Badie N, Muthumala A, Sporton Set al. . Electrocardiographic imaging demonstrates electrical synchrony improvement by dynamic atrioventricular delays in patients with left bundle branch block and preserved atrioventricular conduction. Europace 2023;25:536–45. PubMed PMC
Sami A, Mustafa B, Butt HA, Ashraf Z, Ullah A, Babar Fet al. . Echocardiography- versus intracardiac electrocardiogram-based optimization of cardiac resynchronization therapy: a systematic review. Ann Noninvasive Electrocardiol 2023;28:e13040. PubMed PMC
Cannizzaro MT, Chiodi E, Natali M, Montalto C, Malta B, Ferrante Zet al. . Cardiac resynchronization in ischemic heart failure patients: a comparison between therapy guided by cardiac magnetic resonance imaging and 2D-speckle tracking echocardiography 2015. https://epos.myesr.org/poster/esr/ecr2015/C-0190
Zou J, Hua W, Su Y, Xu G, Zhen L, Liang Yet al. . SPECT-guided LV lead placement for incremental CRT efficacy: validated by a prospective, randomized, controlled study. JACC Cardiovasc Imaging 2019;12:2580–3. PubMed
Sohal M, Hamid S, Perego G, Della Bella P, Adhya S, Paisey Jet al. . A multicenter prospective randomized controlled trial of cardiac resynchronization therapy guided by invasive dP/dt. Heart Rhythm O2 2021;2:19–27. PubMed PMC
Şipal A, Bozyel S, Aktas M, Dervis E, Akbulut T, Argan Oet al. . Surface electrogram-guided left ventricular lead placement improves response to cardiac resynchronization therapy. Anatol J Cardiol 2018;19:184–91. PubMed PMC
Bai R, Di Biase L, Mohanty P, Hesselson AB, De Ruvo E, Gallagher PLet al. . Positioning of left ventricular pacing lead guided by intracardiac echocardiography with vector velocity imaging during cardiac resynchronization therapy procedure. J Cardiovasc Electrophysiol 2011;22:1034–41. PubMed
Bertini M, Mele D, Malagù M, Fiorencis A, Toselli T, Casadei Fet al. . Cardiac resynchronization therapy guided by multimodality cardiac imaging. Eur J Heart Fail 2016;18:1375–82. PubMed
Mele D, Nardozza M, Malagù M, Leonetti E, Fragale C, Rondinella Aet al. . Left ventricular lead position guided by parametric strain echocardiography improves response to cardiac resynchronization therapy. J Am Soc Echocardiogr 2017;30:1001–11. PubMed
Salden OAE, van den Broek HT, van Everdingen WM, Mohamed Hoesein FAA, Velthuis BK, Doevendans PAet al. . Multimodality imaging for real-time image-guided left ventricular lead placement during cardiac resynchronization therapy implantations. Int J Cardiovasc Imaging 2019;35:1327–37. PubMed PMC
Wouters PC, van Lieshout C, van Dijk VF, Delnoy PPHM, Doevendans PAFM, Cramer MJet al. . Advanced image-supported lead placement in cardiac resynchronisation therapy: protocol for the multicentre, randomised controlled ADVISE trial and early economic evaluation. BMJ Open 2021;11:e054115. PubMed PMC
Kronborg MB, Frausing MHJP, Svendsen JH, Johansen JB, Riahi S, Haarbo Jet al. . Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for heart failure? Am Heart J 2023;263:112–22. PubMed
Simader F, Arnold A, Whinnett Z. Comparison of methods for delivering cardiac resynchronization therapy: electrical treatment targets and mechanisms of action. Expert Rev Med Devices 2023;20:337–48. PubMed